Navigation Links
Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance
Date:2/24/2012

CHADDS FORD, Pa., Feb. 24, 2012 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today reported financial results for the fourth quarter of 2011.

Total revenues during the fourth quarter of 2011 increased 57 percent to $803.4 million, compared with $511.2 million in the same quarter of 2010.  Net income for the three months ended Dec. 31, 2011, was $36.6 million, compared with $93.0 million in the comparable 2010 period.  

Additionally, adjusted net income for the three months ended Dec. 31, 2011, was $168.2 million, up 32 percent, compared with $127.6 million in the same period in 2010.  Reported diluted earnings per share for the quarter ended Dec. 31, 2011, were $0.30 compared with $0.77 reported in the fourth quarter of 2010. Adjusted diluted earnings per share for the same period were $1.40, up 32 percent from $1.06 reported in 2010.

"Endo has built a diversified platform of healthcare businesses that span branded pharmaceuticals, generics, medical devices and services, and our 2011 financial performance reinforces the execution of our growth strategy and evolution through acquisition, as well as the organic contributions and strengths of each of our business segments," said Dave Holveck, president and CEO of Endo. "We look forward to updating our investors on the sustainable growth story of our diversified business and how we are exploring new ways to deliver integrated solutions that create value for key constituencies."FINANCIAL PERFORMANCE AT A GLANCE($ in thousands, except per share amounts)4th QuarterTwelve Months Ended
December 3120112010Change20112010ChangeTotal Revenues$803,406

$511,190

57%

$2,730,121

$1,716,229

59%Reported Net Income36,594

92,985

(61)%

187,613

259,006

(28)%Reported Diluted EPS0.30

0.77

(61)%

1.55

2.20


'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
2. Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference
3. Anthera Pharmaceuticals to Present at the Citi Global Health Care Conference
4. Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update
5. Savient Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
6. Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference
7. Satori Pharmaceuticals Raises $15M in New Funding
8. Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and Mexico
9. Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma
10. Endo Pharmaceuticals to Present at Cowen & Co. 32nd Annual Health Care Conference
11. Idenix Pharmaceuticals to Present at the Citi Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Sept. 23, 2014 The Pennsylvania State Police will ... 27, as part of National Prescription Drug Take-Back Day. ... Take-Back Day is a national initiative, conducted ... aimed at encouraging the public to dispose of expired, ... abuse and theft. From 10 a.m. to ...
(Date:9/23/2014)... AVIV, Israel , Sept. 23, 2014 /PRNewswire/ ... ) ("Galmed"), a clinical-stage biopharmaceutical company focused on ... therapy for the treatment of liver diseases and ... and Drug Administration, or the FDA, approved its ... candidate, aramchol, for the treatment of Non-Alcoholic Steato-Hepatitis, ...
(Date:9/23/2014)...  Vesselon, Inc. today announced the appointment of Jurgen ... 15, 2014. Dr. Raths, appointment follows Vesselon,s engagement with ... market a private preferred Series A round to facilitate ... "Jurgen,s deep experience across multiple functional areas of ... Vesselon as we develop our device that can be ...
Breaking Medicine Technology:Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH 2Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH 3Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 2Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 3
... (NYSE: DGX ), the world,s leading provider of ... of Directors declared a quarterly cash dividend of $0.17 per ... of Quest Diagnostics common stock on April 3, 2012. ... is the world,s leading provider of diagnostic testing, information and ...
... For the first time, consumers shopping for over-the-counter ... system that appears on the skin, affecting as ... joint and tendon disease—will find a National Psoriasis ... experts deem effective in relieving disease symptoms. Learn ...
Cached Medicine Technology:National Psoriasis Foundation Launches "Seal of Recognition" for Psoriasis Products 2National Psoriasis Foundation Launches "Seal of Recognition" for Psoriasis Products 3
(Date:9/23/2014)... By Karen Pallarito ... -- Imagine if doctors and hospitals got paid for providing ... consumers had better data for making informed health choices. ... health system is headed. The report, from the IMS ... of change" -- recent events expected to alter the delivery ...
(Date:9/23/2014)... 23, 2014 What information do ... National Quality Forum (NQF) released a report ( ... and an infographic ( http://bit.ly/1tX3lzA ) resulting from ... healthcare, how patients define affordability, and what information ... the best possible healthcare at the lowest possible ...
(Date:9/23/2014)... recent Oregon survey about an exercise DVD that adds ... of elementary school students found it had a high ... offered clear advantages for overly sedentary educational programs. , ... by the Healthy Youth Program of the Linus Pauling ... , Brain Breaks leads children in 5-7 minute segments ...
(Date:9/23/2014)... California (PRWEB) September 23, 2014 ... Oracle services market. Included are Oracle Managed ... Augmentation. Trevera supports all versions of Oracle E-Business ... point releases. , Trevera has announced a ... organizations that need help with their software technology ...
(Date:9/23/2014)... September 23, 2014 Risperdal lawsuits ( ... the country, Bernstein Liebhard LLP reports. According to an ... Florida on September 19th, the Court has dismissed fraud ... in that jurisdiction on behalf of a man who ... due to his use of Risperdal. In dismissing the ...
Breaking Medicine News(10 mins):Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 3
... be the greatest advance in waking up since coffee, ... wake up,in the morning feeling refreshed and ready to go, ... performance to spousal,relations and even driving ability. Fortunately, a unique ... a pill you take before,bedtime that will help you to ...
... specialty bio-therapeutics company developing high-value human,therapeutic proteins for commercialization, will hold its Annual ... Wednesday, April 9, 2008, Time: ... The National Club ... Toronto, Ontario Mr. ...
... look in your,medicine cabinet -- do you spot ... the nation,s dramatic increase in irresponsible,prescription drug use? ... 71 percent of prescription pain medication abusers,obtained the ... 13-year-olds,prescription drug abuse actually exceeds marijuana use., ...
... Awareness ... Month, PRINCETON, N.J., April 8, ... U.S. raising,awareness regarding the poor state of sexual health in America and urging,Americans ... and the Evolve tour is designed to address this head on by,inspiring a ...
... The appearance of a cold sore is,a sign that ... serious,illnesses emerge, according to John Sherman, ND, noted naturopathic,physician ... between 80% and 90% of the adult population have ... to Dr. Sherman, who,is the author of The Complete ...
... Moses and his,wife Ida thought they were doing everything ... multiple medical problems, Moses had an ugly,uncomfortable sore on ... go,away., Dr. Harris Greenberger, Director of Sound Foot ... and Stamford Hospitals in,Connecticut, diagnosed it as a diabetic ...
Cached Medicine News:Health News:Tired Mother Invents Pill to Wake You Up On Time 2Health News:Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure 2Health News:Prescription Drug Abuse Threatens Availability of Pain Medication 2Health News:Video: Rubber Hits the Road as Trojan(R) Campaigns for Sexual Health in America to Evolve 2Health News:Video: Rubber Hits the Road as Trojan(R) Campaigns for Sexual Health in America to Evolve 3Health News:A Cold Sore Is Often A Warning Sign of Deeper Health Issues, Expert Says 2Health News:Living Cell Treatment Heals Diabetic Foot Sores Fast 2
The Properdin ELISA Kit is approved for in-vitro diagnostic use and measurement of properdin serum levels, relevant in cases of recurrent meningococcal infection and recurrent bacterial meningitis....
Inquire...
... can be used for a variety of vacuum needs ... or volatile fumes., Quiet running operation ... changes forever , Chemically Resistant ... solvents such as acids and organics. ...
High-intensity 300-watt xenon lamp, with continuously adjustable output from 0 to 100% manually or automatically by camera video output signal....
Medicine Products: